Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland
Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.
Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetic and generic products.
Suir Pharma Ireland is an independent contract manufacturing company working with many established pharmaceutical companies worldwide. Formerly a Stada AG manufacturing site, Suir Pharma Ireland is well known as an established manufacturer of generic medicines for more than 40 years with the highest quality standards. The company supplies various markets in Europe and the USA.
mutares AG is an industrial holding company that focuses on the acquisition of companies currently finding themselves in a special situation, such as owner or management succession, strategic repositioning and re-funding.
Oaklins' team in Slovakia advised the buyer in this transaction.
Sprechen Sie mit dem Deal-Team
Transaktionen
Bolster Investment Partners hat eine Mehrheitsbeteiligung an Eternal Sun erworben
Bolster Investment Partners, eine in den Niederlanden ansässige Investmentfirma, hat eine Mehrheitsbeteiligung an Eternal Sun, einem weltweit führenden Technologieunternehmen für hochentwickelte Solarmodul-Testsysteme, von ABN AMRO Sustainable Impact Fund, einem privaten Impact Fund mit Sitz in den Niederlanden, und Vermec, einer in Belgien ansässigen Investmentfirma, erworben.
Mehr erfahrenCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahren